AKT1 and hepatocellular carcinoma: In hepatocellular carcinoma, mTOR blockade not only hindered PI3K/AKT/mTOR signal but also reduced the concentration and stability of FBP1/2, thus restraining the proliferation of hepatocellular carcinoma cells (30).